Clinical trial of compound pholcodine combined with cefaclor in treating acute respiratory tract infection in children
10.13699/j.cnki.1001-6821.2024.04.005
- VernacularTitle:复方福尔可定联合头孢克洛治疗小儿急性呼吸道感染的临床研究
- Author:
Xiao-Yan HUANG
1
;
Wei YU
;
Ying-Min DENG
;
Wei-Ying WANG
Author Information
1. 广州市妇女儿童医疗中心儿内科,广东广州 510620
- Keywords:
compound pholcodine;
cefaclor;
acute respiratory tract infection;
children;
clinical efficacy;
inflammatory indicators
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(4):501-504
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the efficacy of compound pholcodine combined with cefaclor in the treatment of acute respiratory tract infection in children and its influence on inflammatory indicators.Methods The children with acute respiratory tract infection were randomly divided into control group and treatment group.The control group was given cefaclor treatment(20 mg·kg-1·d-1,q8 h,with water,for 7 days),and the treatment group was also given compound pholcodine on the basis of the control group(6 months-2 years old,2.5 mL·time-1,tid;2-6 years old,5 mL·time-1,tid;＞6 years old,10 mL·time-1,tid,for 7 days).The clinical efficacy,clinical symptom disappearance time,inflammatory indicators[white blood cell count(WBC),C-reactive protein(CRP),serum amyloid A(SAA),procalcitonin(PCT)]and occurrence of adverse drug reactions during treatment were compared between the two groups.Results 30 cases were dropped out during treatment,and 50 cases were finally included in treatment group and control group respectively.After treatment,the total effective rates in treatment group and control group were 96.00％(48 cases/50 cases)and 82.00％(41 cases/50 cases)respectively,and the difference was statistically significant(P＜0.05).The fever disappearance times were(1.49±0.23)and(2.55±0.57)d;the disappearance times of sore throat were(3.03±0.52)and(4.28±0.71)d;the disappearance times of runny nose and nasal obstruction were(2.46±0.50)and(3.76±0.84)d;the disappearance times of cough were(3.51±0.38)and(4.59±0.46)d;WBC levels were(7.25±1.41)and(8.49±1.60)x 109·L-1;CRP levels were(2.55±0.63)and(4.09±0.78)mg·L1;SAA levels were(29.42±4.88)and(37.15±6.24)mg·L-1;PCT levels were(0.81±0.15)and(0.93±0.18)ng·mL-1,respectively(all P＜0.05).The main adverse drug reactions in treatment group were dizziness(1 case),vomiting(1 case)and mild drowsiness(1 case),and the main adverse drug reactions in control group were diarrhea(1 case)and vomiting(1 case).The total incidence rates of adverse drug reactions in treatment group and control group were 6.00％(3 cases/50 cases)and 4.00％(2 cases/50 cases)(P＞0.05).Conclusion Compound pholcodine combined with cefaclor has a significant efficacy in the treatment of acute respiratory tract infection in children,and it can reduce the levels of inflammatory indicators.
